✦ LIBER ✦

Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?

✍ Scribed by Anne C Armstrong, David E Gilham

Book ID: 118726903
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 91 KB
Volume: 14
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr3184

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination With Protein-Transduced Dend

Vaccination With Protein-Transduced Dendritic Cells Elicits a Sustained Response to Hepatitis C Viral Antigens

✍ Noriyoshi Kuzushita; Stephen H. Gregory; Nola A. Monti; Rolf Carlson; Stephan Ge 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Co-targeting of the PI3K pathway improve

Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition

✍ Siker Kimbung; Ewa Biskup; Ida Johansson; Kristina Aaltonen; Astrid Ottosson-Wad 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 919 KB

Dendritic cell-based tumor vaccine for c

Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7

✍ Marion Nonn; Manuela Schinz; Klaus Zumbach; Michael Pawlita; Achim Schneider; Ma 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 348 KB

Targeting of the non-mutated tumor antig

Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice

✍ Bei Wang; Neeha Zaidi; Li-Zhen He; Li Zhang; Janelle MY Kuroiwa; Tibor Keler; Ra 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 537 KB

Effects of granulocyte-macrophage colony

Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides

✍ Carmen Scheibenbogen; Dirk Schadendorf; Nikolaos E. Bechrakis; Dirk Nagorsen; Ud 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 316 KB

## Abstract Immunologic adjuvants are used to augment the immunogenicity of MHC class I–restricted peptide vaccines, but this effect has rarely been systematically evaluated in a clinical trial. We have investigated, in a phase I study, whether addition of the 2 adjuvants GM‐CSF and KLH can enhance

Vaccination with p53 peptide-pulsed dend

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

✍ Inge Marie Svane; Anders E. Pedersen; Julia S. Johansen; Hans E. Johnsen; Dorte 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 478 KB